177 related articles for article (PubMed ID: 20061293)
1. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis.
Lev I; Kelekar G; Waxman A; Yu R
Endocr Pract; 2010; 16(3):398-407. PubMed ID: 20061293
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
Campeau RJ; Garcia OM; Correa OA; Rege AB
South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
Furuta N; Kiyota H; Yoshigoe F; Hasegawa N; Ohishi Y
Int J Urol; 1999 Mar; 6(3):119-24. PubMed ID: 10226821
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
[TBL] [Abstract][Full Text] [Related]
6. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.
Greenblatt DY; Shenker Y; Chen H
Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis of pheochromocytoma by 131I-MIBG scintigraphy].
Miyanaga N; Hattori K; Shiraiwa H; Hinotsu S; Nemoto R; Koiso K; Takeda T; Ishikawa N
Hinyokika Kiyo; 1990 Feb; 36(2):105-8. PubMed ID: 2343801
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
9. Detecting pheochromocytoma: defining the most sensitive test.
Guller U; Turek J; Eubanks S; Delong ER; Oertli D; Feldman JM
Ann Surg; 2006 Jan; 243(1):102-7. PubMed ID: 16371743
[TBL] [Abstract][Full Text] [Related]
10. A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Cecchin D; Lumachi F; Marzola MC; Opocher G; Scaroni C; Zucchetta P; Mantero F; Bui F
Endocr Relat Cancer; 2006 Jun; 13(2):525-33. PubMed ID: 16728579
[TBL] [Abstract][Full Text] [Related]
11. [Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy].
Noblet-Dick M; Grunenberger F; Brunot B; Jaeck D; Schlienger JL
Rev Med Interne; 2003 Jun; 24(6):358-65. PubMed ID: 12814824
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging.
Ishii S; Shishido F; Miyajima M; Sakuma K; Kikuchi K
Clin Nucl Med; 2012 Jun; 37(6):596-8. PubMed ID: 22614196
[TBL] [Abstract][Full Text] [Related]
13. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
14. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
Miskulin J; Shulkin BL; Doherty GM; Sisson JC; Burney RE; Gauger PG
Surgery; 2003 Dec; 134(6):918-22; discussion 922-3. PubMed ID: 14668723
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
[TBL] [Abstract][Full Text] [Related]
16. Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.
Berglund AS; Hulthén UL; Manhem P; Thorsson O; Wollmer P; Törnquist C
J Intern Med; 2001 Mar; 249(3):247-51. PubMed ID: 11285044
[TBL] [Abstract][Full Text] [Related]
17. Complete remission of metastatic pheochromocytoma in
Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 131I-metaiodobenzylguanidine scintigraphy with urinary and plasma catecholamine determinations in the diagnosis of pheochromocytoma.
Plewe G; Beyer J; Krause U; Cordes U; Eissner D; Hahn K
Klin Wochenschr; 1985 Jul; 63(14):627-30. PubMed ID: 4032986
[TBL] [Abstract][Full Text] [Related]
19. Iodine-131-MIBG scintigraphy in adults: interpretation revisited?
Roelants V; Goulios C; Beckers C; Jamar F
J Nucl Med; 1998 Jun; 39(6):1007-12. PubMed ID: 9627334
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
